PUBLIC COMPANY
saveiCell Gene Therapeutics LLC
updated 21d ago
community read0 votes
pipeline
2
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(2)
pipeline depth2 products
2Phase 1
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1BCMA-CD19 cCAR-T for the Treatment of Refractory Inflammatory Myopathy
- phase2BCMA-CD19 cCAR T for the Treatment of Refractory Inflammatory Bowel Disease (IBD)
- phase2BCMA-CD19 cCAR T for the Treatment of Refractory Lupus
- phase1BCMA-CD19 cCAR in Multiple Myeloma and Plasmacytoid Lymphoma
- phase1BCMA-CD19 CCAR T Cell Treatment of Refractory Immune Thrombocytopenia Associated with Autoimmune Diseases
🐶 Hiring Signal
News
no news has mentioned this company yet
comments(0)
5-min edit window · permanent after that